Literature DB >> 24565568

Integration of automated morphological features resolves a distinct group of atypical chronic lymphocytic leukemias with chromosomal aberrations.

Yair Herishanu1, Sigi Kay2, Erel Joffe2, Jonathan Ben-Ezra1, Shoshana Baron2, Rachel Rotman3, Rony Braunstein2, Nili Dezorella2, Aaron Polliack2, Elizabeth Naparstek1, Chava Perry2, Varda Deutsch2, Ben-Zion Katz4.   

Abstract

Automated morphological assessment of peripheral blood slides has become an important modality facilitating characterization and quantification of cells in a uniform, fast and robust manner. In this study, we evaluated the morphological diversity in peripheral blood films of 94 chronic lymphocytic leukemia (CLL) patients using the DM1200 CellaVision automated microscopy system. Aberrant lymphocytes and smudge cells were enumerated and correlated with CLL immunophenotype, chromosomal aberrations and prognostic parameters. Herein, we show that the percentages of aberrant and smudge cells was highly variable between patients and did not correlate with each other. Increased aberrant lymphocytes and fewer smudge cells were associated with an atypical immunophenotype including low expression of CD23, higher levels of FMC7 and bright surface levels of CD20. High fraction of aberrant lymphocytes also was associated with trisomy 12. These cells were predominantly of small/medium size, sometimes with cleft nuclei. No correlation was noted between aberrant or smudge cells and clinical stage, CD38, ZA70 or time to first treatment. Taken together, automated morphological analysis of peripheral blood leukocytes emerged as a powerful and robust tool for the quantitative morphological stratification of CLL. Integration of the automated morphological features discriminates between different CLL phenotypes and distinct chromosomal aberrations.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aberrant morphology; CLL; Chromosomal abnormalities; Peripheral blood

Mesh:

Year:  2014        PMID: 24565568     DOI: 10.1016/j.leukres.2014.01.008

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  2 in total

1.  Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia.

Authors:  Pietro Bulian; Riccardo Bomben; Michele Dal Bo; Antonella Zucchetto; Francesca Maria Rossi; Massimo Degan; Federico Pozzo; Tamara Bittolo; Vanessa Bravin; Tiziana D'Agaro; Michaela Cerri; Annalisa Chiarenza; Kari G Chaffee; Adalgisa Condoluci; Giovanni D'Arena; Michele Spina; Francesco Zaja; Gabriele Pozzato; Francesco Di Raimondo; Davide Rossi; Giovanni Del Poeta; Gianluca Gaidano; Tait D Shanafelt; Valter Gattei
Journal:  Haematologica       Date:  2017-07-27       Impact factor: 9.941

2.  Red and white blood cell morphology characterization and hands-on time analysis by the digital cell imaging analyzer DI-60.

Authors:  Oh Joo Kweon; Yong Kwan Lim; Mi-Kyung Lee; Hye Ryoun Kim
Journal:  PLoS One       Date:  2022-04-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.